HDFC Pharma and Healthcare Fund Direct Growth NFO
Equity
Direct
Sector - Healthcare
NAV: ₹ 10 as on 28-09-2023
About the Fund
HDFC Pharma and Healthcare Fund Direct Growth is an equity new fund offer (NFO) launched by HDFC Asset Management Co Ltd. The investors can apply to the NFO from 14 September 2023 to 28 September 2023. As per the SEBI defined riskometer, the HDFC Pharma and Healthcare Fund Direct Growth is rated Very High Risk. HDFC Pharma and Healthcare Fund Direct Growth has defined its benchmark as Nifty 500.
HDFC Pharma and Healthcare Fund Direct Growth Overview
 | ₹ 10 |
 | 14 September 2023 |
| 28 September 2023 |
 | 05 October 2023 |
 Exit Load | 1% |
 Benchmark | S&P BSE Healthcare TR INR |
Peer Analysis
Frequently Asked Questions
HDFC Pharma and Healthcare Fund Direct Growth NFO (new fund offer) start date: 2023-09-14.
HDFC Pharma and Healthcare Fund Direct Growth NFO (new fund offer) close date: 2023-09-28.
HDFC Pharma and Healthcare Fund Direct Growth NFO (new fund offer) NAV: Rs. ₹10.
is the Fund Manager of HDFC Pharma and Healthcare Fund Direct Growth as per NFO filings?
HDFC Pharma and Healthcare Fund Direct Growth NFO (new fund offer) allotment date: 2023-10-05